[11C]-methionine PET: Dysembryoplastic neuroepithelial tumours compared with other epileptogenic brain neoplasms

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 76, Issue 12, 2005, Pages 1686-1692

  Rosenberg, D S ^a   Demarquay, G ^a   Jouvet, A ^a   Le Bars, D ^a   Streichenberger, N ^a   Sindou, M ^a   Kopp, N ^a   Mauguiere F ^a   Ryvlin, P ^a  

^a HÔPITAL NEUROLOGIQUE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM; METHIONINE C 11; CARBON; DIAGNOSTIC AGENT; METHIONINE;

ADOLESCENT; ADULT; ARTICLE; BRAIN REGION; BRAIN TUMOR; CHILD; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE DURATION; DYSEMBRYOPLASTIC NEUROEPITHELIAL TUMOR; EPILEPSY; FEMALE; GLIOMA; HUMAN; MALE; NEUROEPITHELIOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIODIAGNOSIS; TERATOMA; TUMOR LOCALIZATION; COMPARATIVE STUDY; MIDDLE AGED; PROSPECTIVE STUDY; SCINTISCANNING;

ADOLESCENT; ADULT; BRAIN NEOPLASMS; CARBON RADIOISOTOPES; CHILD; EPILEPSY; FEMALE; GLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; METHIONINE; MIDDLE AGED; NEOPLASMS, NEUROEPITHELIAL; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; TERATOMA;

EID: 28144457698     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.2004.051607     Document Type: Article

References (53)

1. Wolf HK, Wiestler OD. Surgical pathology of chronic epileptic seizure disorders. Brain Pathol 1993;3:371-80.
2. Plate KH, Wieser HG, Yasargil MG, et al. Neuropathological findings in 224 patients with temporal lobe epilepsy. Acta Neuropathol 1993;86:433-8.
3. Pasquier B, Bost F, Peoc'h M, et al. Neuropathological findings in resective surgery for medically intractable epilepsy. Ann Pathol 1996;16:174-81.
4. Pasquier B, Péoc'h M, Fabre-Bocquentin B, et al. Surgical pathology of drug-resistant partial epilepsy. A 10-year-experience with a series of 327 consecutives resections. Epileptic Disord 2002;4:99-119.
5. Fried I, Kim JH, Spencer DD. Limbic and neocortical gliomas associated with intractable seizure: a distinct clinicopathological group. Neurosurgery 1994;34:815-24.
6. Bartolomei JC, Christopher S, Vives K, et al. Low-grade gliomas of chronic epilepsy: a distinct clinical and pathological entity. J Neurooncol 1997;34:79-84.
7. Honavar M, Janota I, Polkey CE. Histological heterogeneity of dysembryoplastic neuroepithelial tumor: identification and differential diagnosis in a series of 74 cases. Histopathology 1999;34:342-56.
8. Daumas-Duport C, Scheitauer BW, Chodkiewicz, et al. Dysembryoplastic neuroepithelial tumor: a surgical curable tumor of young patients with intractable partial seizures. Report of 39 cases. Neurosurgery 1988;23:545-56.
9. Daumas-Duport C. Dysembryoplastic neuroepithelial tumours. Brain Pathol 1993;3:283-95.
10. Kleihues P, Cavenee WK. Pathology and Genetic Tumours of the Nervous System. Lyon: IARC Press, 2000.
11. Miller DC, Lang FF, Epstein FJ. Central nervous system gangliogliomas. Part 1: Pathology. J Neurosurg 1993;79:859-66.
12. Rumana CS, Valadka AB. Radiation therapy and malignant degeneration of benign supratentorial gangliogliomas, Neurosurgery 1998;42:1038-43.
13. Rushing EJ, Thompson LD, Mena H. Malignant transformation of a dysembryoplastic neuroepithelial tumor after radiation and chemotherapy. Ann Diagn Pathol 2003;7:240-4.
14. Hammond RR, Duggal N, Woulfe JMJ, et al. Malignant transformation of a dysembryoplastic neuroepithelial tumor. Case report. J Neurosurg 2000;92:722-5.
15. Stanescu Cosson R, Varlet P, Beuvon F, et al. Dysembryoplastic neuroepithelial tumors: CT, MR findings and imaging follow-up: a study of 53 cases. J Neuroradiol 2001;28:230-40.
16. Di Chiro G, De La Paz RL, Brooks RA, et al. Glucose utilization of cerebral gliomas measured by 18 fluorodeoxyglucose and positron emission tomography. Neurology 1982;32:1323-9.
17. 18F] fluorodeoxyglucose in brain tumors: A powerful diagnostic and prognostic tool. Invest Radiol 1986;22:360-71.
18. Di Chiro G, Brooks RA. PET-FDG of untreated and treated cerebral gliomas. J Nucl Med 1988;29:421-2.
19. Coleman RE, Hoffman JM, Hanson MW, et al. Clinical application of PET for the evaluation of brain tumors. J Nucl Med 1991;32:616-22.
20. 18F-fluorodeoxyglucose. J Neurooncol 1991;10:85-91.
21. Roelcke U. PET: brain tumor biochemistry. J Neurooncol 1994;22:275-9.
22. 68Ga-EDTA in supratentorial tumors. J Comput Assist Tomogr 1985;9:683-9.
23. 11C methionine and PET. AJNR Am J Neuroradiol 1985;6:505-14.
24. 11C-L-Methionine. J Neurooncol 1986;3:397-404.
25. Mineura K, Sasajima T, Kowada M, et al. Innovative approach in the diagnosis of gliomatosis cerebri using Carbon-11-L-Methionine PET. J Nucl Med 1991;32:726-8.
26. 11C-L-Methionine uptake in gliomas. Neurosurgery 1989;25:720-8.
27. 11C-L-methionine. Neurosurgery 1997;40:276-88.
28. Derlon JM, Chapon F, Noël MH, et al. Non-invasive grading of oligodendrogliomas: correlations between in vivo metabolic pattern and histopafhology. Eur J Nucl Med 2000;27:778-7.
29. Ogawa T, Shishido F, Kanno I, et al. Cerebral gliomas: evaluation with methionine PET. Radiology 1993;186:45-53.
30. 11C-methionine. AJNR Am J Neuroradiol 1996;17:345-53.
31. 11C-Methionine PET for differential diagnosis of low-grade gliomas. Neurology 1998;50:1316-22.
32. Kaschten B, Stevenaert A, Sadzot B, et al. Preoperative evaluation of 54 gliomas by PET with Fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine. J Nucl Med 1998;39:778-85.
33. Roelcke U, Radü EW, Hausmann O, et al. Tracer transport and metabolism in a patient with juvenile pilocytic astrocytoma. A PET study. J Neurooncol 1998;36:279-83.
34. De Witte O, Goldberg I, Wikler D, et al. PET with injection of methionine as a prognostic factor in glioma. J Neurosurg 2001;95:746-50.
35. Provenzale JM, Arata MA, Turkington TG, et al. Gangliogliomas: characterization by registered PET-MR images. AJR Am J Roentgenol 1999;172:1103-7.
36. 201Tl-SPECT. AJNR Am J Neuroradiol 1998;19:801-6.
37. Meyer PT, Spetzger U, Mueller H, et al. High F18-FDG uptake in a low-grade supratentorial gliomas: a PET case report. Clin Nucl Med 2000;25:694-7.
38. 11C-L-methionine to metabolically characterise dysembryoplastic neuroepithelial tumors. J Child Neurol 1999;14:673-7.
39. 11C- Methionine PET in the diagnosis of dysembryoplastic neuroepithelial tumor with temporal lobe epilepsy. Epilepsia 2004;45:41-5.
40. Varlet P, Beuvon F, Fallet-Bianco C, et al. Dysembryoplastic neuroepithelial tumors. Ann Pathol 2000;20:429-37.
41. Kracht LW, Friese M, Herholz K, et al. Methyl-[11C]-L-methionine uptake as measured by positron emission tomography correlates to microvessel density in patients with glioma. Eur J Nucl Med Mol Imaging 2003;30:868-73.
42. Woesler B, Kuwert T, Kulermann G. High amino-acid uptake in a low-grade desmoplastic infantile ganglioglioma in a 14-year-old patient. Neurosurg Rev 1998;21:31-5.
43. 11C-L-methionine uptake in cerebral gliomas: a comparative study using PET and SPECT. J Nucl Med 1997;38:517-22.
44. Johnstone RM, Scholefield PG. Amino-acid transport in tumor cells. In: Haddow A, Weinhouse S, eds. Advances in Cancer Research. Edinburgh: Academic Press, 1965:9.
45. 3H-methyl-L-methionine. J Nucl Med 2000;41:1250-5.
46. Bergström M, Ericson K, Hagenfeldt L, et al. PET study of methionine accumulation in glioma and normal brain tissue: competition with branched chain amino acids. J Comput Assist Tomogr 1987;11:208-13.
47. Ishiwata K, Kubota K, Murakami M, et al. M. Re-evaluation of amino acid PET studies: can the protein synthesis rates in brain and tumor tissues be measured in vivo. J Nucl Med 1993;34:1936-43.
48. Sato N, Suzuki M, Kuwata N, et al. Evaluation of the malignancy of glioma using 11-C-methionine positron emission tomography and proliferating cell nuclear antigen staining. Neurosurg Rev 1999;22:210-14.
49. Wolf HK, Müller MB, Spänle M, et al. Ganglioglioma: a detailed histopathological and immunohistochemical analysis of 61 cases. Acta Neuropathol 1994;88:166-73.
50. Prayson RA, Khajavi K, Comair YG. Cortical architectural abnormalities and MIB1 immunoreactivity in gangliogliomas: a study of 60 patients with intracranial tumors. J Neuropathol Exp Neurol 1995;54:513-20.
51. Prayson RA, Morris HH, Estes ML, et al. Dysembryoplastic neuroepithelial tumor: a clinical an immunohistochemical study of 11 tumors including MIB1 immunoreactivity. Clin Neuropathol 1996;15:47-53.
52. Raymond AA, Halpin SF, Alsanjari N, et al. Dysembryoplastic neuroepithelial tumour. Features in 16 patients. Brain 1994;117:461-75.
53. 11C-methionine and rubidium-82 using PET. J Neurol Sci 1995;132:20-7.